Loading...

Pacira BioSciences, Inc.

PCRXNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$22.55
$0.73(3.35%)

Pacira BioSciences, Inc. (PCRX) Company Profile & Overview

Explore Pacira BioSciences, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Pacira BioSciences, Inc. (PCRX) Company Profile & Overview

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOFrank D. Lee

Contact Information

813 553 6680
5401 West Kennedy Boulevard, Tampa, FL, 33609

Company Facts

788 Employees
IPO DateFeb 3, 2011
CountryUS
Actively Trading

Frequently Asked Questions

;